Operating Lease, Liability of Summit Therapeutics Inc. from 01 Feb 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Summit Therapeutics Inc. quarterly Operating Lease, Liability in USD history and change rate from 01 Feb 2018 to 31 Dec 2024.
  • Summit Therapeutics Inc. Operating Lease, Liability for the quarter ending 31 Dec 2024 was $7,218,000, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $7,218,000 +$1,119,000 +18% 31 Dec 2024 10-K 24 Feb 2025 2024 FY
Q4 2023 $6,099,000 +$1,646,000 +37% 31 Dec 2023 10-K 20 Feb 2024 2023 FY
Q4 2022 $4,453,000 +$1,671,000 +60% 31 Dec 2022 10-K 09 Mar 2023 2022 FY
Q4 2021 $2,782,000 +$2,317,000 +498% 31 Dec 2021 10-K/A 21 Dec 2022 2021 FY
Q4 2020 $465,000 -$428,000 -48% 31 Dec 2020 10-K 31 Mar 2021 2020 FY
Q4 2019 $893,000 31 Dec 2019 8-K 29 Sep 2020 2020 Q2
Q4 2017 $1,800,000 01 Feb 2018 8-K 29 Sep 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.